These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31572437)

  • 1. Predictive and Prognostic Value of Selected MicroRNAs in Luminal Breast Cancer.
    Amorim M; Lobo J; Fontes-Sousa M; Estevão-Pereira H; Salta S; Lopes P; Coimbra N; Antunes L; Palma de Sousa S; Henrique R; Jerónimo C
    Front Genet; 2019; 10():815. PubMed ID: 31572437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
    Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
    J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel prognostic and predictive microRNA targets for triple-negative breast cancer.
    Turashvili G; Lightbody ED; Tyryshkin K; SenGupta SK; Elliott BE; Madarnas Y; Ghaffari A; Day A; Nicol CJB
    FASEB J; 2018 May; ():fj201800120R. PubMed ID: 29812973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
    Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
    Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of microRNAs in Throat Swab as the Biomarkers for Diagnosis of Influenza.
    Peng F; He J; Loo JF; Yao J; Shi L; Liu C; Zhao C; Xie W; Shao Y; Kong SK; Gu D
    Int J Med Sci; 2016; 13(1):77-84. PubMed ID: 26917988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
    Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P
    Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapy.
    Zhong X; Xie G; Zhang Z; Wang Z; Wang Y; Wang Y; Qiu Y; Li L; Bu H; Li J; Zheng H
    Oncotarget; 2016 Sep; 7(38):61166-61182. PubMed ID: 27533459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
    Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-microRNA Biomarker Signatures to Classify Breast Cancer Subtypes.
    Oztemur Islakoglu Y; Noyan S; Aydos A; Gur Dedeoglu B
    OMICS; 2018 Nov; 22(11):709-716. PubMed ID: 30388053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
    Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
    Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer.
    Petrelli A; Bellomo SE; Sarotto I; Kubatzki F; Sgandurra P; Maggiorotto F; Di Virgilio MR; Ponzone R; Geuna E; Galizia D; Nuzzo AM; Medico E; Miglio U; Berrino E; Venesio T; Ribisi S; Provero P; Sapino A; Giordano S; Montemurro F
    ESMO Open; 2020 Oct; 5(5):e000937. PubMed ID: 33122354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNAs in Sera of Tunisian patients discriminate between inflammatory breast cancer and non-inflammatory breast cancer.
    Hamdi K; Goerlitz D; Stambouli N; Islam M; Baroudi O; Neili B; Benayed F; Chivi S; Loffredo C; Jillson IA; Benammar Elgaaied A; Blancato JK; Marrakchi R
    Springerplus; 2014; 3():636. PubMed ID: 26034677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.